💨 Abstract

Twist Bioscience Corp. reported fiscal third-quarter earnings of $20.4 million, exceeding Wall Street expectations. The company posted a profit of 33 cents per share, while adjusted losses were 47 cents per share. Revenue was $96.1 million, surpassing analyst forecasts of $95.5 million.

Courtesy: WTOP Staff